-
Niacin may not be effective in preventing cardiovascular disease.
-
The FDA has approved two new drugs for the treatment of hepatitis C the first new drugs to be approved in years.
-
-
The FDA has approved linagliptin for the treatment of type 2 diabetes in adults.
-
A new study points out the risk of nonsteroidal anti-inflammatory drug (NSAID) use in patients who have had a myocardial infarction (MI) suggesting that even brief use increases the risk for death and recurrent MI.
-
-
Stedman's medical dictionary defines lethargy as a "relatively mild impairment of consciousness resulting in reduced alertness and awareness; this condition has many causes but is ultimately due to generalized brain dysfunction."
-
The utility of inflammatory markers in acute pericarditis is not well understood. Thus, these investigators from Italy prospectively evaluated serial high sensitivity C-reactive protein (hs-CRP) serum levels in patients with acute pericarditis followed for 24 months on average.
-
In a cohort of mechanically ventilated patients admitted with a variety of acute diagnoses, those diagnosed with COPD (but not in exacerbation) had higher ICU mortality but no difference in risk for ventilator-associated pneumonia as compared to patients without the diagnosis of COPD.
-
This observational study noted that critically ill patients provided with clinical psychological support during their ICU stay had less anxiety, depression, and post-traumatic stress disorder at one year post-discharge compared to historical controls.